Cargando…

sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)

OBJECTIVE: A high ratio of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) has been linked to pre‐eclampsia (PE). We evaluated the sFlt‐1/PlGF ratio as a predictive marker for early‐onset PE in women at risk of PE. METHODS: This prospective, Spanish, multicenter study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Perales, A., Delgado, J. L., de la Calle, M., García‐Hernández, J. A., Escudero, A. I., Campillos, J. M., Sarabia, M. D., Laíz, B., Duque, M., Navarro, M., Calmarza, P., Hund, M., Álvarez, F. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836987/
https://www.ncbi.nlm.nih.gov/pubmed/27883242
http://dx.doi.org/10.1002/uog.17373
_version_ 1783304046673657856
author Perales, A.
Delgado, J. L.
de la Calle, M.
García‐Hernández, J. A.
Escudero, A. I.
Campillos, J. M.
Sarabia, M. D.
Laíz, B.
Duque, M.
Navarro, M.
Calmarza, P.
Hund, M.
Álvarez, F. V.
author_facet Perales, A.
Delgado, J. L.
de la Calle, M.
García‐Hernández, J. A.
Escudero, A. I.
Campillos, J. M.
Sarabia, M. D.
Laíz, B.
Duque, M.
Navarro, M.
Calmarza, P.
Hund, M.
Álvarez, F. V.
author_sort Perales, A.
collection PubMed
description OBJECTIVE: A high ratio of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) has been linked to pre‐eclampsia (PE). We evaluated the sFlt‐1/PlGF ratio as a predictive marker for early‐onset PE in women at risk of PE. METHODS: This prospective, Spanish, multicenter study included pregnant women with a risk factor for PE, including intrauterine growth restriction, PE, eclampsia or hemolysis, elevated liver enzymes and low platelet count syndrome in previous pregnancy, pregestational diabetes or abnormal uterine artery Doppler. The primary objective was to show that the sFlt‐1/PlGF ratio at 20, 24 and 28 weeks' gestation was predictive of early‐onset PE (< 34 + 0 weeks). Serum sFlt‐1 and PlGF were measured at 20, 24 and 28 weeks. Multivariate logistic regression was used to develop a predictive model. RESULTS: A total of 819 women were enrolled, of which 729 were suitable for analysis. Of these, 78 (10.7%) women developed PE (24 early onset and 54 late onset). Median sFlt‐1/PlGF ratio at 20, 24 and 28 weeks was 6.3 (interquartile range (IQR), 4.1–9.3), 4.0 (IQR, 2.6–6.3) and 3.3 (IQR, 2.0–5.9), respectively, for women who did not develop PE (controls); 14.5 (IQR, 5.5–43.7), 18.4 (IQR, 8.2–57.9) and 51.9 (IQR, 11.5–145.6) for women with early‐onset PE; and 6.7 (IQR, 4.6–9.9), 4.7 (IQR, 2.8–7.2) and 6.0 (IQR, 3.8–10.5) for women with late‐onset PE. Compared with early‐onset PE, the sFlt‐1/PlGF ratio was significantly lower in controls (P < 0.001 at each timepoint) and in women with chronic hypertension (P < 0.001 at each timepoint), gestational hypertension (P < 0.001 at each timepoint) and late‐onset PE (P < 0.001 at each timepoint). A prediction model for early‐onset PE was developed, which included the sFlt‐1/PlGF ratio plus mean arterial pressure, being parous and previous PE, with areas under the receiver–operating characteristics curves of 0.86 (95% CI, 0.77–0.95), 0.91 (95% CI, 0.85–0.97) and 0.93 (95% CI, 0.86–0.99) at 20, 24 and 28 weeks, respectively, and was superior to models using the sFlt‐1/PlGF ratio alone or uterine artery mean pulsatility index. CONCLUSIONS: The sFlt‐1/PlGF ratio can improve prediction of early‐onset PE for women at risk of this condition. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
format Online
Article
Text
id pubmed-5836987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-58369872018-03-12 sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain) Perales, A. Delgado, J. L. de la Calle, M. García‐Hernández, J. A. Escudero, A. I. Campillos, J. M. Sarabia, M. D. Laíz, B. Duque, M. Navarro, M. Calmarza, P. Hund, M. Álvarez, F. V. Ultrasound Obstet Gynecol Original Papers OBJECTIVE: A high ratio of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) has been linked to pre‐eclampsia (PE). We evaluated the sFlt‐1/PlGF ratio as a predictive marker for early‐onset PE in women at risk of PE. METHODS: This prospective, Spanish, multicenter study included pregnant women with a risk factor for PE, including intrauterine growth restriction, PE, eclampsia or hemolysis, elevated liver enzymes and low platelet count syndrome in previous pregnancy, pregestational diabetes or abnormal uterine artery Doppler. The primary objective was to show that the sFlt‐1/PlGF ratio at 20, 24 and 28 weeks' gestation was predictive of early‐onset PE (< 34 + 0 weeks). Serum sFlt‐1 and PlGF were measured at 20, 24 and 28 weeks. Multivariate logistic regression was used to develop a predictive model. RESULTS: A total of 819 women were enrolled, of which 729 were suitable for analysis. Of these, 78 (10.7%) women developed PE (24 early onset and 54 late onset). Median sFlt‐1/PlGF ratio at 20, 24 and 28 weeks was 6.3 (interquartile range (IQR), 4.1–9.3), 4.0 (IQR, 2.6–6.3) and 3.3 (IQR, 2.0–5.9), respectively, for women who did not develop PE (controls); 14.5 (IQR, 5.5–43.7), 18.4 (IQR, 8.2–57.9) and 51.9 (IQR, 11.5–145.6) for women with early‐onset PE; and 6.7 (IQR, 4.6–9.9), 4.7 (IQR, 2.8–7.2) and 6.0 (IQR, 3.8–10.5) for women with late‐onset PE. Compared with early‐onset PE, the sFlt‐1/PlGF ratio was significantly lower in controls (P < 0.001 at each timepoint) and in women with chronic hypertension (P < 0.001 at each timepoint), gestational hypertension (P < 0.001 at each timepoint) and late‐onset PE (P < 0.001 at each timepoint). A prediction model for early‐onset PE was developed, which included the sFlt‐1/PlGF ratio plus mean arterial pressure, being parous and previous PE, with areas under the receiver–operating characteristics curves of 0.86 (95% CI, 0.77–0.95), 0.91 (95% CI, 0.85–0.97) and 0.93 (95% CI, 0.86–0.99) at 20, 24 and 28 weeks, respectively, and was superior to models using the sFlt‐1/PlGF ratio alone or uterine artery mean pulsatility index. CONCLUSIONS: The sFlt‐1/PlGF ratio can improve prediction of early‐onset PE for women at risk of this condition. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. John Wiley & Sons, Ltd 2017-09-05 2017-09 /pmc/articles/PMC5836987/ /pubmed/27883242 http://dx.doi.org/10.1002/uog.17373 Text en © 2016 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Papers
Perales, A.
Delgado, J. L.
de la Calle, M.
García‐Hernández, J. A.
Escudero, A. I.
Campillos, J. M.
Sarabia, M. D.
Laíz, B.
Duque, M.
Navarro, M.
Calmarza, P.
Hund, M.
Álvarez, F. V.
sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title_full sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title_fullStr sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title_full_unstemmed sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title_short sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
title_sort sflt‐1/plgf for prediction of early‐onset pre‐eclampsia: steps (study of early pre‐eclampsia in spain)
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836987/
https://www.ncbi.nlm.nih.gov/pubmed/27883242
http://dx.doi.org/10.1002/uog.17373
work_keys_str_mv AT peralesa sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT delgadojl sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT delacallem sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT garciahernandezja sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT escuderoai sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT campillosjm sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT sarabiamd sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT laizb sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT duquem sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT navarrom sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT calmarzap sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT hundm sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT alvarezfv sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain
AT sflt1plgfforpredictionofearlyonsetpreeclampsiastepsstudyofearlypreeclampsiainspain